vs

Side-by-side financial comparison of ALERUS FINANCIAL CORP (ALRS) and Axogen, Inc. (AXGN). Click either name above to swap in a different company.

Axogen, Inc. is the larger business by last-quarter revenue ($61.5M vs $45.2M, roughly 1.4× ALERUS FINANCIAL CORP). Axogen, Inc. runs the higher net margin — -31.9% vs -73.2%, a 41.3% gap on every dollar of revenue. On growth, Axogen, Inc. posted the faster year-over-year revenue change (26.6% vs 18.0%). ALERUS FINANCIAL CORP produced more free cash flow last quarter ($58.8M vs $-1.4M). Over the past eight quarters, Axogen, Inc.'s revenue compounded faster (13.3% CAGR vs -2.5%).

Alerus Financial Corporation, marketed as simply Alerus, is a chain of financial institutions headquartered in Grand Forks, North Dakota, with locations in North Dakota, Minnesota, Wisconsin, and Arizona. Alerus offers banking, mortgage, wealth management, and retirement services.

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

ALRS vs AXGN — Head-to-Head

Bigger by revenue
AXGN
AXGN
1.4× larger
AXGN
$61.5M
$45.2M
ALRS
Growing faster (revenue YoY)
AXGN
AXGN
+8.6% gap
AXGN
26.6%
18.0%
ALRS
Higher net margin
AXGN
AXGN
41.3% more per $
AXGN
-31.9%
-73.2%
ALRS
More free cash flow
ALRS
ALRS
$60.2M more FCF
ALRS
$58.8M
$-1.4M
AXGN
Faster 2-yr revenue CAGR
AXGN
AXGN
Annualised
AXGN
13.3%
-2.5%
ALRS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALRS
ALRS
AXGN
AXGN
Revenue
$45.2M
$61.5M
Net Profit
$-33.1M
$-19.6M
Gross Margin
75.2%
Operating Margin
-96.0%
20.2%
Net Margin
-73.2%
-31.9%
Revenue YoY
18.0%
26.6%
Net Profit YoY
-49232.8%
-410.8%
EPS (diluted)
$-1.27
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALRS
ALRS
AXGN
AXGN
Q1 26
$61.5M
Q4 25
$45.2M
$59.9M
Q3 25
$72.6M
$60.1M
Q2 25
$74.8M
$56.7M
Q1 25
$68.8M
$48.6M
Q4 24
$72.2M
$49.4M
Q3 24
$50.9M
$48.6M
Q2 24
$51.4M
$47.9M
Net Profit
ALRS
ALRS
AXGN
AXGN
Q1 26
$-19.6M
Q4 25
$-33.1M
$-13.2M
Q3 25
$16.9M
$708.0K
Q2 25
$20.3M
$579.0K
Q1 25
$13.3M
$-3.8M
Q4 24
$-67.0K
$450.0K
Q3 24
$5.2M
$-1.9M
Q2 24
$6.2M
$-1.9M
Gross Margin
ALRS
ALRS
AXGN
AXGN
Q1 26
75.2%
Q4 25
74.1%
Q3 25
76.6%
Q2 25
74.2%
Q1 25
71.9%
Q4 24
76.1%
Q3 24
74.9%
Q2 24
73.8%
Operating Margin
ALRS
ALRS
AXGN
AXGN
Q1 26
20.2%
Q4 25
-96.0%
-16.3%
Q3 25
30.4%
3.2%
Q2 25
35.2%
3.0%
Q1 25
25.5%
-3.4%
Q4 24
-0.8%
4.1%
Q3 24
13.4%
-0.6%
Q2 24
15.8%
-0.9%
Net Margin
ALRS
ALRS
AXGN
AXGN
Q1 26
-31.9%
Q4 25
-73.2%
-22.0%
Q3 25
23.3%
1.2%
Q2 25
27.1%
1.0%
Q1 25
19.4%
-7.9%
Q4 24
-0.2%
0.9%
Q3 24
10.2%
-3.8%
Q2 24
12.1%
-4.0%
EPS (diluted)
ALRS
ALRS
AXGN
AXGN
Q1 26
$-0.38
Q4 25
$-1.27
$-0.28
Q3 25
$0.65
$0.01
Q2 25
$0.78
$0.01
Q1 25
$0.52
$-0.08
Q4 24
$-0.06
$-0.00
Q3 24
$0.26
$-0.04
Q2 24
$0.31
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALRS
ALRS
AXGN
AXGN
Cash + ST InvestmentsLiquidity on hand
$67.2M
$82.7M
Total DebtLower is stronger
$59.2M
Stockholders' EquityBook value
$564.9M
$244.8M
Total Assets
$5.2B
$289.5M
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALRS
ALRS
AXGN
AXGN
Q1 26
$82.7M
Q4 25
$67.2M
$41.5M
Q3 25
$92.0M
$35.8M
Q2 25
$80.9M
$29.9M
Q1 25
$83.0M
$22.1M
Q4 24
$61.2M
$33.5M
Q3 24
$66.0M
$24.5M
Q2 24
$438.1M
$21.1M
Total Debt
ALRS
ALRS
AXGN
AXGN
Q1 26
Q4 25
$59.2M
$48.4M
Q3 25
$59.2M
$48.2M
Q2 25
$59.1M
$47.9M
Q1 25
$59.1M
$47.7M
Q4 24
$59.1M
$47.5M
Q3 24
$59.0M
$47.3M
Q2 24
$59.0M
$47.0M
Stockholders' Equity
ALRS
ALRS
AXGN
AXGN
Q1 26
$244.8M
Q4 25
$564.9M
$128.8M
Q3 25
$550.7M
$120.8M
Q2 25
$533.2M
$112.3M
Q1 25
$514.2M
$105.4M
Q4 24
$495.4M
$103.9M
Q3 24
$386.5M
$99.4M
Q2 24
$373.2M
$95.7M
Total Assets
ALRS
ALRS
AXGN
AXGN
Q1 26
$289.5M
Q4 25
$5.2B
$221.7M
Q3 25
$5.3B
$216.4M
Q2 25
$5.3B
$205.5M
Q1 25
$5.3B
$196.2M
Q4 24
$5.3B
$203.7M
Q3 24
$4.4B
$192.0M
Q2 24
$4.4B
$188.9M
Debt / Equity
ALRS
ALRS
AXGN
AXGN
Q1 26
Q4 25
0.10×
0.38×
Q3 25
0.11×
0.40×
Q2 25
0.11×
0.43×
Q1 25
0.11×
0.45×
Q4 24
0.12×
0.46×
Q3 24
0.15×
0.48×
Q2 24
0.16×
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALRS
ALRS
AXGN
AXGN
Operating Cash FlowLast quarter
$67.5M
Free Cash FlowOCF − Capex
$58.8M
$-1.4M
FCF MarginFCF / Revenue
130.2%
-2.3%
Capex IntensityCapex / Revenue
19.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$102.4M
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALRS
ALRS
AXGN
AXGN
Q1 26
Q4 25
$67.5M
$3.0M
Q3 25
$32.8M
$3.2M
Q2 25
$10.7M
$7.7M
Q1 25
$7.7M
$-13.2M
Q4 24
$21.7M
$8.7M
Q3 24
$20.2M
$3.9M
Q2 24
$-12.5M
$4.2M
Free Cash Flow
ALRS
ALRS
AXGN
AXGN
Q1 26
$-1.4M
Q4 25
$58.8M
$1.8M
Q3 25
$30.3M
$1.7M
Q2 25
$7.6M
$7.0M
Q1 25
$5.7M
$-13.4M
Q4 24
$9.4M
$8.1M
Q3 24
$17.4M
$3.3M
Q2 24
$-16.1M
$3.3M
FCF Margin
ALRS
ALRS
AXGN
AXGN
Q1 26
-2.3%
Q4 25
130.2%
3.0%
Q3 25
41.8%
2.8%
Q2 25
10.1%
12.4%
Q1 25
8.2%
-27.7%
Q4 24
13.0%
16.3%
Q3 24
34.2%
6.8%
Q2 24
-31.4%
6.8%
Capex Intensity
ALRS
ALRS
AXGN
AXGN
Q1 26
Q4 25
19.3%
2.1%
Q3 25
3.4%
2.5%
Q2 25
4.2%
1.3%
Q1 25
3.0%
0.5%
Q4 24
17.1%
1.4%
Q3 24
5.4%
1.2%
Q2 24
7.2%
1.9%
Cash Conversion
ALRS
ALRS
AXGN
AXGN
Q1 26
Q4 25
Q3 25
1.94×
4.55×
Q2 25
0.53×
13.35×
Q1 25
0.58×
Q4 24
19.41×
Q3 24
3.88×
Q2 24
-2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALRS
ALRS

Other$17.3M38%
Retirement And Benefit Services$17.3M38%
Wealth Management$7.4M16%
Mortgage Banking$3.2M7%

AXGN
AXGN

Segment breakdown not available.

Related Comparisons